Another interesting blog post from Alan Hoffman

Alan Hoffman, one of the participants in the first Georgetown University nilotinib trial for PD, has just added a new post to his blog (17 Nov 2016).

In this post he makes reference to the program BIG, and to the drugs Rytary and Tasigna (nilotinib), which he is taking.


Last edited by

    You may also like...